Form D · Biotechnology
Mel-Mont Medical, Inc.
Doral, FL · CIK 0001832591
Offering snapshot reported Dec 17, 2025 · SEC filing
- Reported sold
- $250K Offering amount: $5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 11, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 17, 2025 | Initial | $250,000 | No comparison | 3 | SEC filing |
| Dec 16, 2025 | Amendment | $6,902,021 | $6,852,021vs Sep 21, 2023 | 69 | SEC filing |
| Sep 21, 2023 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Nov 20, 2020 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-567168
Source: Form D, filed Dec 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Octavio Gonzalez Paredo | Director, Executive |
| Frank Melendez | Director, Executive |
| Liliana Montes | Director, Executive |
| Michael Torres | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11467 Nw 34 Th Street
Doral, FL, 33178
Doral, FL, 33178